Genentech brings ops savvy, pipeline to Roche

Despite its pipeline-enhancing objective, the acquisition of Genentech by Roche is showing a nod by the centenarian drugmaker to the upstart's operations talents. Genentech scientists are stepping into key manufacturing jobs for Roche--global manufacturing chief Pat Yang and North American commercial ops chief Ian Clark are two examples.

Similarly, Genentech operations have fared well in a post-merger manufacturing shake-up.  The Swiss drug giant closed its Palo Alto, CA, facility and cut hundreds of jobs in New Jersey.

By a more common metric, Genentech's generated revenue per employee of $1.2 million in 2008 bests Roche's $528,000, according to Bloomberg.

- here's the article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.